1991 Volume 84 Issue 9 Pages 1333-1338
Included in the present study are 65 patients with sudden deafness treated with Solu-Medrol® starting within two weeks of the onset in our university hospital and seven related hospitals Nov. 1987-Dec. 1989.
The dose of Solu-Medrole was initially 500mg and it was gradually diminished there after. Audiometry was repeated until the results were stabilized.
The results were 34% complete recovery, 21% definite improvement, 25% slight improvement, 20% no improvement.
These results are similar to those reported for other therapies. The outstanding difference is the better results in patients with hearing loss of more than 91dB; 92% of them improved more than 10dB in the averaged pure tone hearing.
It is concluded that Solu-Medrole is useful for the treatment of sudden deafness, especially for severe cases of more than 91dB loss.
